Icure Pharmaceutical Inc. recorded nine buy transactions totaling 11.87 million KRW over the past ninety days. Four insiders, including directors Ahn Young Kyun and Choi Young Jong, participated in these acquisitions. No sales occurred during this period, reflecting consistent accumulation by leadership without any recent public disclosure regarding their latest results.